Therapeutic Approach

Archive: February, 2018

Ritter Pharmaceuticals Appoints Distinguished Gastroenterologist, William Chey, M.D., to Medical Advisory Board

LOS ANGELES, Feb. 20, 2018 (GLOBE NEWSWIRE) — Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutics that modulate the gut microbiome to treat gastrointestinal diseases with an initial focus on establishing the first FDA-approved treatment for lactose intolerance, today announced the appointment of William Chey, M.D., to its Medical […]

Leave Your Comments »

Featuring Recent Posts WordPress Widget development by YD